Table 2.

Final group numbers (n), number of outliers removed (HC, SI-SAL, SI-PHY, EtOH-SAL, EtOH-PHY), and statistical results for all factorial ANOVAs (see F and p values) for each gene (c-Fos, Arc, Egr-1, and Npas4) in each region (mPFC, dHPC, and vHPC) for Experiment 2.

Medial Prefrontal Cortex (mPFC)					Dorsal Hippocampus (dHPC)				Ventral Hippocampus (vHPC)
	F	p	Final n	Outliers	F	p	Final n	Outliers	F	p	Final n	Outliers
Genes		(HC, SI-SAL, SI-PHY, EtOH-SAL, EtOH-PHY)				(HC, SI-SAL, SI-PHY, EtOH-SAL, EtOH-PHY)				(HC, SI-SAL, SI-PHY, EtOH-SAL, EtOH-PHY)
c-Fos
Dosing	4.53	< .05			0.58	> .45			0.73	> .39
Drug	7.63	< .01	23, 11, 8, 12, 12	1, 1, 1, 0, 0	21.59	< .01	21, 10, 10, 11, 11	2, 1, 1, 0, 0	1.53	> .23	22, 10, 10, 11, 9	2, 1, 1, 1, 0
Dosing × Drug	7.56	< .01			0.12	> .70			4.37	< .05
Arc
Dosing	20.26	< .01			0.11	> .74			0.01	> .90
Drug	18.13	< .01	22, 11, 9, 10, 11	2, 1, 0, 2, 1	0.1	> .74	21, 10, 10, 10, 10	2, 1, 1, 1, 1	1.55	>.22	22, 10, 10, 11, 10	2, 1, 1, 1, 1
Dosing × Drug	0.04	> .80			0.03	> .87			1.71	> .19
Egr-1
Dosing	12.03	< .01			0.54	> .45			0.14	> .70
Drug	2.94	> .10	22, 11, 9, 11, 10	2, 1, 0, 1, 2	2.83	> .10	20, 11, 10, 10, 10	1, 1, 1, 1, 1	1.85	> .18	22, 10, 10, 11, 10	2, 1, 1, 1, 1
Dosing × Drug	2.51	> .12			2.75	> .10			0.08	> .77
Npas4
Dosing	19.2	< .01			0.22	> .64			0.35	> .56
Drug	9.55	< .01	23, 12, 9, 11, 11	1, 0, 0, 1, 1	0.49	> .48	21, 11, 11, 11, 11	2, 0, 0, 1, 0	0.07	> .79	22, 10, 10, 12, 10	2, 1, 1, 0, 1
Dosing × Drug	0.49	> .48			0.01	> .90			0.43	> .50